Time heals all? The science of ‘Long Covid’

By Lauren Jordan

When SARS-CoV-2, a novel coronavirus, was isolated in January 2020 the world feared the immediate pathological response to infection with the virus. However, it was only with the emergence of post-Covid-19 syndrome, or ‘Long Covid’ that the world grew to realise the full extent of Covid-19’s wrath and the stamp it would leave on the lives of many.

Now, the World Health Organisation (WHO) estimates that 10-20% of people infected with Covid-19 experience a diverse and complex range of disabling long-term symptoms, predominantly characterised by neurocognitive issues and fatigue.

Over two years since the pandemic began, researchers are therefore working to decipher the effects of Covid-19 at the cellular and molecular level, and how these confer the long-term effects that infection can entail.

Covid-19 is capable of wreaking havoc through impairing the expression of cytoprotective proteins and enzymes

So far, many symptoms appear to be underpinned by the fact that Covid-19 is an endothelial disease, which means that it targets cells lining many of the body’s organs and cavities, notably including blood vessels and the heart.

Following entry to these endothelial cells, Covid-19 is capable of wreaking havoc through impairing the expression of cytoprotective proteins and enzymes that usually prevent damage to the cells caused by reactive oxygen species (ROS), highly reactive molecules capable of damaging cellular macromolecules such as DNA.  

As all organs are perfused by small blood vessels called capillaries, damage to these aligns with the multitude of organs that Long Covid is observed in. For example, breathlessness may be caused by capillary dysfunction in respiratory muscles or more seriously cardiac or lung fibrosis, whilst ‘brain fog’ could be explained by impaired blood flow through capillaries in the cortical regions of the brain.

Covid-19 also infects astrocytes in the brain, preventing their transfer of glucose and lactate to neurons which could offer an additional explanation for ‘brain fog’ alongside other neurological symptoms such as depression and anxiety. Similarly, loss of smell may be due to a disruption of biochemicals being delivered to olfactory neurons by olfactory epithelial sustentacular cells due to due to localisation of the ACE-2 protein on the latter which allows for viral entry to the cell.

This supports the idea that Covid-19 may be a ‘lingering’ virus and therefore persists, replicating in many organs many months after initial infection.

However, like most pathologies, it is likely that the triggers don’t act alone, but rather in conjunction with, or even amplifying others. Therefore, it may be that in the presence of a persisting virus, a destabilised immune system cannot reset to idle.

Immunologist Chansavath Phetsouphanh of the University of New South Wales found the immune systems of Long Covid patients were constantly in high alert, with white blood cells highly activated and ready to recruit other immune cells to an infection site, but with a striking absence of inactivated B and T cells which mediate the actions to counter the pathogen.

Collectively this entails a state of chronic inflammation and therefore, drugs capable of combatting the actions of ROS have been highlighted as a promising treatment option. For example, the hormone melatonin has been identified as a candidate to ease symptoms as it activates NRF2, a transcription factor, to synthesise an antioxidant known as glutathione to counter ROS attack. Melatonin appears safe for chronic use.

SARS-CoV-2 is not unique in its ability to cause postinfectious syndromes

However, despite an absence of an internationally-agreed treatment pathway, many people left feeling mere shadows of their former selves by Long Covid are jumping the gun and opting for any available treatment out of pure desperation for a life devoid of its debilitating effects.  

A huge surge in procedures have been seen in Cyprus, Germany, and Switzerland at private clinics. Popular amongst these are apheresis or ‘blood washing’ which is a blood filtering treatment usually used for lipid disorders, and anti-clotting therapy.

Gitee Boumeester, a trainee psychiatrist in the Netherlands, paid €50,000 (£42,376) for six rounds of apheresis alongside an intravenous drip, and nine rounds of hyperbaric oxygen therapy at the Long Covid Centre in Cyprus. Despite all this, she returned home with no improvement in her condition.

Some doctors and researchers believe that these treatments are not pseudoscientific and do show some promise, however with no concrete proof of efficacy, and many, like Gitee, not seeing any results, the eye-wateringly high prices for unproven treatment leave many sceptical of the idea.

Some fear that treatments as experimental and invasive as these could have dangerous consequences and should remain contained in the boundaries of clinical trials.

Notably, SARS-CoV-2 is not unique in its ability to cause postinfectious syndromes: unexplained chronic disability, akin to Long Covid, following acute infection has been documented with other coronaviruses, such as MERS, as well as with many other viruses.

Therefore, advancements in understanding underlying mechanisms and treatments will have significant implications for patching this blind spot in the field of medicine and importantly, will better equip humans to deal with, and adapt to, potential future pandemics.

Illustration: Nicole Wu